NYSE:ZTSPharmaceuticals
Zoetis Outlook Cut Highlights Slower Vet Visits And Long Term Pipeline
Zoetis (NYSE:ZTS) lowered its 2026 outlook, citing a decline in veterinary visits that is affecting demand for pet healthcare services.
The update highlights changing conditions in the pet care market while the company continues to reference support from its product pipeline and longer term investor interest.
Zoetis is a major animal health company, with products spanning pet medicines, vaccines and diagnostics that are widely used in veterinary clinics. The reduction in its 2026 outlook...